“Runaway” AI, “rogue” agents, and “autonomous” actors—the current rhetoric would have you believe that AI agents are not only awake and aware, but angry at their creators. Prominent tech leaders such as Demis Hassabis, Dario Amodei, and Sam Altman push for regulation of these seemingly “superhuman” systems, while a separate faction, led by policy organizations…
LinkedIn is introducing new ways to reduce low-quality AI-generated posts, including a “seems like AI slop” reporting option. It’s also replacing its own AI writing feature with a proofreading tool.
Financial planning gets all the attention in a business sale — but the identity, community and sense of purpose you lose the day you sign are what most founders never prepare for, and what defines whether the exit was actually worth it.
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Spotify says the new feature is designed to let users add personal captions to their favorite songs, such as noting why a track was added to a playlist or when they first discovered it